Physician profile
John Lee
NPI 1154389344
$2,000.30
in general payments reported to CMS, 2019-2025
18 companies · $71.35 in 2025
The $71.35 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.24 · 2020: $108 · 2021: $582 · 2022: $412 · 2023: $331 · 2024: $409 · 2025: $71.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $811.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $471.24 | 2021-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $366.78 | 2021-2024 | Dupixent, Libtayo |
| Genzyme Corporation | $326.30 | 2019-2025 | |
| Cochlear Americas | $150.99 | 2023-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Sanofi-Aventis U.S. LLC | $129.54 | 2021-2022 | |
| Stryker Corporation | $111.17 | 2019-2024 | Na |
| Polynovo North America LLC | $82.20 | 2023-2024 | Novosorb Btm |
| Glaxosmithkline, LLC. | $80.43 | 2021-2025 | Nucala |
| Neurent Medical Limited | $62.64 | 2024 | Neuromark Radiofrequency Console, Neuromark Device |
| Allergan, INC. | $45.48 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $36.24 | 2021-2023 | |
| Smith+Nephew, INC. | $31.79 | 2024 | Tula |
| Intersect Ent, INC. | $24.47 | 2019 | |
| Med-El Corporation | $19.86 | 2019 | |
| Phathom Pharmaceuticals, INC. | $18.51 | 2024 | Voquezna |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $16.17 | 2024 | Mounjaro |
| Kowa Pharmaceuticals America, INC. | $14.43 | 2023 | Seglentis |
| Arbor Pharmaceuticals, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.